Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis

DAA therapy is known to clear hepatitis C virus infection in patients with decompensated cirrhosis (DC). However, the safety and benefits of DAA in DC remain unclear, especially with the use of protease inhibitors (PI). Therefore, we evaluated the efficacy and clinical safety of DAA in DC patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: An, JiHyun, Park, Dong Ah, Ko, Min Jung, Ahn, Sang Bong, Yoo, Jeong-Ju, Jun, Dae Won, Yim, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506163/
https://www.ncbi.nlm.nih.gov/pubmed/36143302
http://dx.doi.org/10.3390/jpm12091517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506163/
https://www.ncbi.nlm.nih.gov/pubmed/36143302
http://dx.doi.org/10.3390/jpm12091517

Ejemplares similares